The patented nRichDX Revolution System overcomes the challenge of biomarker distinction from biological fluids by providing high volume, high-yield, efficient recovery and high reproduceability. An industry leading 80% recovery rate coupled with up to 50 mL sample volume equates to exponentially more analyte captured, increasing molecular downstream test sensitivity.
Dartmouth-Hitchcock Medical Center will present a posted showing data obtained using our platform:
Poster TT044 | Abstract 16939 | Technical Topics category
Poster TT039 | Abstract 16906 | Technical Topics category